(Q45090413)

9 December 2017

title

Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine (English)

1 reference

9 December 2017

0 references

3

Raymond F Schinazi

1 reference

9 December 2017

2

Ghazia Asif

1 reference

9 December 2017

Selwyn J Hurwitz

1

1 reference

9 December 2017

publication date

1 January 2007

1 reference

Antiviral Chemistry & Chemotherapy

9 December 2017

published in

1 reference

9 December 2017

volume

18

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

329-341

1 reference

Indinavir concentrations and antiviral effect

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Virus dynamics and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

How does HIV cause AIDS? The homing theory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Confronting the emergence of drug-resistant HIV type 1: impact of antiretroviral therapy on individual and population resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Pharmacologic considerations for therapeutic success with antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Identifiability and indistinguishability of nonlinear pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Lymphocyte response to phytohemagglutinin: intracellular volume and intracellular [K+]

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Adherence in AIDS clinical trials: a framework for clinical research and clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Anti-HIV drug development--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Nucleoside and nucleobase transport in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Drug Resistance Profiles of Recombinant Reverse Transcriptases from Human Immunodeficiency Virus Type 1 Subtypes A/E, B, and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

A long-term latent reservoir for HIV-1: discovery and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Structural identifiability of PBPK models: practical consequences for modeling strategies and study designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Modeling plasma virus concentration during primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Model-based approaches to biomarker discovery and evaluation: a multidisciplinary integrated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Adherence and drug resistance: predictions for therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020701800605

10.1177/095632020701800605

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference